An investigation of the C77G and C772T variations within the human protein tyrosine phosphatase receptor type C gene for association with multiple sclerosis in an Australian population

Brain Research

Volumn 1255, Issue , 2009, Pages 148-152

  Szvetko, Attila L ^a   Jones, Ashleigh ^a   Mackenzie, Jason ^a   Tajouri, Lotti ^a   Csurhes, Peter A ^b   Greer, Judith M ^b   Pender, Michael P ^b   Griffiths, Lyn R ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

CD45; Genetic variation; HRM; Multiple sclerosis; RFLP

Indexed keywords

BETA INTERFERON;

ANALYTIC METHOD; ARTICLE; AUSTRALIA; C772T GENE; C77G GENE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HIGH RESOLUTION MELT ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE C GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ALLELES; ANTIGENS, CD45; AUSTRALIA; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 58949088296     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.12.017     Document Type: Article

References (27)

1. Barcellos L.F., Caillier S., Dragone L., Elder M., Vittinghoff E., Bucher P., Lincoln R.R., Pericak-Vance M., Haines J.L., Weiss A., Hauser S.L., and Oksenberg J.R. PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patients. Nat. Genet. 29 (2001) 23-24
2. Boxall S., Stanton T., Hirai K., Ward V., Yasui T., Tahara H., Tamori A., Nishiguchi S., Shiomi S., Ishiko O., Inaba M., Nishizawa Y., Dawes R., Bodmer W., Beverley P.C., and Tchilian E.Z. Disease associations and altered immune function in CD45 138G variant carriers. Hum. Mol. Genet. 13 (2004) 2377-2384
3. Consortium T.I.H. The international HapMap project. Nature 426 (2003) 789-796
4. Erali M., Voelkerding K.V., and Wittwer C.T. High resolution melting applications for clinical laboratory medicine. Exp. Mol. Pathol. (2008)
5. Faul F., Erdfelder E., Lang A.G., and Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Meth. 39 (2007) 175-191
6. Genain C.P., Cannella B., Hauser S.L., and Raine C.S. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5 (1999) 170-175
7. Hauser S.L. An update on multiple sclerosis. J. Neurol. Sci. 228 (2005) 193-194
8. Hennig B.J., Fry A.E., Hirai K., Tahara H., Tamori A., Moller M., Hopkin J., Hill A.V., Bodmer W., Beverley P., and Tchilian E. PTPRC (CD45) variation and disease association studied using single nucleotide polymorphism tagging. Tissue Antigens 71 (2008) 458-463
9. Jacobsen M., Schweer D., Ziegler A., Gaber R., Schock S., Schwinzer R., Wonigeit K., Lindert R.B., Kantarci O., Schaefer-Klein J., Schipper H.I., Oertel W.H., Heidenreich F., Weinshenker B.G., Sommer N., and Hemmer B. A point mutation in PTPRC is associated with the development of multiple sclerosis. Nat. Genet. 26 (2000) 495-499
10. Jacobsen M., Hoffmann S., Cepok S., Stei S., Ziegler A., Sommer N., and Hemmer B. A novel mutation in PTPRC interferes with splicing and alters the structure of the human CD45 molecule. Immunogenetics 54 (2002) 158-163
11. Lassmann H., Bruck W., and Lucchinetti C.F. The immunopathology of multiple sclerosis: an overview. Brain Pathol. 17 (2007) 210-218
12. Nakahara J., Seiwa C., Tan-Takeuchi K., Gotoh M., Kishihara K., Ogawa M., Asou H., and Aiso S. Involvement of CD45 in central nervous system myelination. Neurosci. Lett. 379 (2005) 116-121
13. Salzer J.L. Switching myelination on and off. J. Cell Biol. 181 (2008) 575-577
14. Shenoi H., Seavitt J., Zheleznyak A., Thomas M.L., and Brown E.J. Regulation of integrin-mediated T-cell adhesion by the transmembrane protein tyrosine phosphatase CD45. J. Immunol. 162 (1999) 7120-7127
15. Stanton T., Boxall S., Hirai K., Dawes R., Tonks S., Yasui T., Kanaoka Y., Yuldasheva N., Ishiko O., Bodmer W., Beverley P.C., and Tchilian E.Z. A high-frequency polymorphism in exon 6 of the CD45 tyrosine phosphatase gene (PTPRC) resulting in altered isoform expression. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 5997-6002
16. Taveggia C., Thaker P., Petrylak A., Caporaso G.L., Toews A., Falls D.L., Einheber S., and Salzer J.L. Type III neuregulin-1 promotes oligodendrocyte myelination. Glia 56 (2008) 284-293
17. Tchilian E.Z., Wallace D.L., Dawes R., Imami N., Burton C., Gotch F., and Beverley P.C. A point mutation in CD45 may be associated with an increased risk of HIV-1 infection. AIDS 15 (2001) 1892-1894
18. Tchilian E.Z., Wallace D.L., Wells R.S., Flower D.R., Morgan G., and Beverley P.C. A deletion in the gene encoding the CD45 antigen in a patient with SCID. J. Immunol. 166 (2001) 1308-1313
19. Trowbridge I.S., and Thomas M.L. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu. Rev. Immunol. 12 (1994) 85-116
20. Uitenbroek D.G. In: Uitenbroek D.G. (Ed). SISA Binomial (1997), Southampton
21. Vincze T., Posfai J., and Roberts R.J. NEBcutter: a program to cleave DNA with restriction enzymes. Nucleic Acids Res. 31 (2003) 3688-3691
22. Vorechovsky I., Kralovicova J., Tchilian E., Masterman T., Zhang Z., Ferry B., Misbah S., Chapel H., Webster D., Hellgren D., Anvret M., Hillert J., Hammarstrom L., and Beverley P.C. Does 77C → G in PTPRC modify autoimmune disorders linked to the major histocompatibility locus?. Nat. Genet. 29 (2001) 22-23
23. Vyshkina T., Leist T.P., Shugart Y.Y., and Kalman B. CD45 (PTPRC) as a candidate gene in multiple sclerosis. Mult. Scler. 10 (2004) 614-617
24. Ward V., Hennig B.J., Hirai K., Tahara H., Tamori A., Dawes R., Saito M., Bangham C., Stephens H., Goldfeld A.E., Kunachiwa W., Leetrakool N., Hopkin J., Dunstan S., Hill A., Bodmer W., Beverley P.C., and Tchilian E.Z. Geographical distribution and disease associations of the CD45 exon 6 138G variant. Immunogenetics 58 (2006) 235-239
25. Weiner H.L. Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease. Arch. Neurol. 61 (2004) 1613-1615
26. Zafranskaya M., Oschmann P., Engel R., Weishaupt A., van Noort J.M., Jomaa H., and Eberl M. Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis. Immunology 121 (2007) 29-39
27. Zhao J.H. 2LD, GENECOUNTING and HAP: computer programs for linkage disequilibrium analysis. Bioinformatics 20 (2004) 1325-1326